Skip to main content

Week In Review: China Biopharma Starts 2021 With Over $1 Billion In Deals And IPOs

Gracell Biotech of Suzhou completed a $209 million NASDAQ IPO for its next-gen CAR-T treatments. APT Medical completed a $191 million IPO on the Shanghai STAR Exchange, rising 245% in its first trading session to a market cap of $2.7 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.